Currently Skimming:
9 Creating a Blueprint for Action
9 Creating a Blueprint for Action
Pages 113-120
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 113... ...
The conclusions and recommendations presented in this chapter were offered by the speakers identified in parentheses in the text and do not represent the consensus of the group or of the conveners of the workshop. DRUG-RESISTANT TB IN INDIA India has been conducting an "amazing" expansion of MDR TB treatment with the goal of achieving universal access to treatment, said Salmaan Keshavjee, Harvard Medical School.
|
From page 114... ...
Conclusions and recommendations offered by individual workshop participants regarding drug-resistant TB in India included the following: • The overall public health care system in India needs to be strength ened to support a strong anti-TB program.
|
From page 115... ...
Tandon, INSA, observed, a 100 percent sensitive and specific test for TB in general and MDR TB in particular still does not exist, and current tests are cumbersome, costly, and difficult to use widely. Some workshop participants also suggested that although the ideal diagnostic test has yet to be developed, more focused and effective efforts should be undertaken to identify MDR TB using current diagnostics.
|
From page 116... ...
Although the incarcerated and others in congregate settings were not discussed extensively at the workshop, Filerman and Keshavjee noted that the prison populations in almost every country have higher rates of TB and MDR TB than the general population and deserve special attention. Conclusions and recommendations offered by individual workshop participants in the area of addressing TB and MDR TB in vulnerable populations included the following: • The burden of drug-resistant TB in vulnerable populations needs to be documented.
|
From page 117... ...
1 COMBATING DRUG-RESISTANT TB THROUGH PUBLIC– PRIVATE COLLABORATION AND INNOVATIVE APPROACHES The majority of people in India access private-sector health care services, which means that engaging private health care providers in the fight against MDR TB is essential. In addition, the volume of anti-TB drugs being disseminated by the private sector suggests that many people being treated for TB are not being recorded by public-sector providers.
|
From page 118... ...
Using Innovative Technologies Technology -- whether cell phones, electronic medical records, laptops, or biometric identification systems -- can facilitate better MDR TB treatment, said Janet Tobias, President, Sierra/Tango Productions, Ikana Media. These technologies can connect health care providers, laboratories, and patients so that treatment can start earlier and be more effective.
|
From page 119... ...
Finally, patients must become partners with health care providers and governments to win the battle against MDR TB. Conclusions and recommendations offered by individual workshop participants with respect to creating partnerships to combat MDR TB included the following: • International partnerships and assistance are essential to address MDR TB in resource-limited settings.
|
From page 120... ...
• Drug logistics guidelines are needed for the drug distribution net work. (Pradeep Saxena, Government of India)
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.